139 related articles for article (PubMed ID: 15658192)
1. A new highly unstable alpha chain variant causing alpha(+)-thalassemia: Hb Zurich Albisrieden [alpha59(E8)Gly-->Arg (alpha2)].
Dutly F; Fehr J; Goede JS; Morf M; Troxler H; Frischknecht H
Hemoglobin; 2004; 28(4):347-51. PubMed ID: 15658192
[TBL] [Abstract][Full Text] [Related]
2. Severe Hb H Disease Caused by Hb Zürich-Albisrieden (
Wu SM; Huang SR; Li C; Chen GL; Li DZ
Hemoglobin; 2022 Nov; 46(6):341-343. PubMed ID: 36815319
[TBL] [Abstract][Full Text] [Related]
3. Hydrops Fetalis Associated with Compound Heterozygosity for Hb Zurich-Albisrieden (HBA2: C.178G > C) and the Southeast Asian (- -
Yang X; Yan JM; Li J; Xie XM; Zhou JY; Li Y; Li DZ
Hemoglobin; 2016 Sep; 40(5):353-355. PubMed ID: 27686733
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the alpha2-globin causing alpha(+)-thalassemia: Hb Plasencia [alpha125(H8)Leu--Arg (alpha2).
Martin G; Villegas A; González FA; Ropero P; Hojas R; Polo M; Mateo M; Salvador M; Benavente C
Hemoglobin; 2005; 29(2):113-7. PubMed ID: 15921163
[TBL] [Abstract][Full Text] [Related]
5. Thalassemia major phenotype caused by HB Zürich-Albisrieden [α2 59(E8) Gly > Arg (HBA2:C.178G > C)] in a Brazilian child.
Pedroso GA; Kimura EM; Santos MNN; Albuquerque DM; Malimpensa D; Jorge SE; Verissimo MPA; Costa FF; Sonati MF
Pediatr Blood Cancer; 2018 Dec; 65(12):e27413. PubMed ID: 30151892
[TBL] [Abstract][Full Text] [Related]
6. Hb Bleuland [alpha108(G15)Thr-->Asn, ACC-->AAC (alpha2)]: a new abnormal hemoglobin associated with a mild alpha-thalassemia phenotype.
Harteveld CL; Versteegh FG; Kok PJ; van Rooijen-Nijdam IH; van Delft P; Giordano PC
Hemoglobin; 2006; 30(3):349-54. PubMed ID: 16840225
[TBL] [Abstract][Full Text] [Related]
7. Two α1-Globin Gene Point Mutations Causing Severe Hb H Disease.
Jiang H; Huang LY; Zhen L; Jiang F; Li DZ
Hemoglobin; 2017; 41(4-6):293-296. PubMed ID: 29115167
[TBL] [Abstract][Full Text] [Related]
8. A rare thalassemic syndrome caused by interaction of Hb Adana [alpha59(E8)Gly-->Asp] with an alpha+-thalassemia deletion: clinical aspects in two cases.
Douna V; Papassotiriou I; Garoufi A; Georgouli E; Ladis V; Stamoulakatou A; Metaxotou-Mavrommati A; Kanavakis E; Traeger-Synodinos J
Hemoglobin; 2008; 32(4):361-9. PubMed ID: 18654886
[TBL] [Abstract][Full Text] [Related]
9. Erythrocytosis due to a combination of the high oxygen affinity hemoglobin variant, Hb Olympia [beta20(B2)Val-->Met] with beta- and alpha-thalassemia mutations: first case in the literature.
Kalotychou V; Tzanetea R; Konstantopoulos K; Papassotiriou I; Rombos I
Hemoglobin; 2010; 34(4):383-8. PubMed ID: 20642336
[TBL] [Abstract][Full Text] [Related]
10. Hb Bronte or alpha93(FG5)Val-->Gly: a new unstable variant of the alpha2-globin gene, associated with a mild alpha(+)-thalassemia phenotype.
Lacerra G; Testa R; De Angioletti M; Schilirò G; Carestia C
Hemoglobin; 2003 Aug; 27(3):149-59. PubMed ID: 12908799
[TBL] [Abstract][Full Text] [Related]
11. Hb Angers: A new α2-globin variant [α2 (140)(HC2) Tyr → Ser; HBA2: C.422 A>C] with increased oxygen affinity leading to erythrocytosis.
Orvain C; Kiger L; Peronet I; Peron A; Galacteros F; Wajcman H; Pissard S
Int J Lab Hematol; 2021 Jun; 43(3):e114-e117. PubMed ID: 33217156
[No Abstract] [Full Text] [Related]
12. Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.
Traeger-Synodinos J; Papassotiriou I; Metaxotou-Mavrommati A; Vrettou C; Stamoulakatou A; Kanavakis E
Blood Cells Mol Dis; 2000 Aug; 26(4):276-84. PubMed ID: 11042028
[TBL] [Abstract][Full Text] [Related]
13. Two new hemoglobin variants: Hb Brem-sur-Mer [beta9(A6)Ser-->Tyr] and Hb Passy [alpha81(F2)Ser-->Pro (alpha2)].
Lacan P; Moreau M; Becchi M; Zanella-Cleon I; Aubry M; Louis JJ; Couprie N; Francina A
Hemoglobin; 2005; 29(1):69-75. PubMed ID: 15768558
[TBL] [Abstract][Full Text] [Related]
14. Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients.
Cürük MA; Dimovski AJ; Baysal E; Gu LH; Kutlar F; Molchanova TP; Webber BB; Altay C; Gürgey A; Huisman TH
Am J Hematol; 1993 Dec; 44(4):270-5. PubMed ID: 8237999
[TBL] [Abstract][Full Text] [Related]
15. Hb Groene Hart: a new Pro-->Ser amino acid substitution at position 119 of the alpha1-globin chain is associated with a mild alpha-thalassemia phenotype.
Harteveld CL; van Delft P; Plug R; Versteegh FG; Hagen B; van Rooijen I; Kok PJ; Wajcman H; Kister J; Giordano PC
Hemoglobin; 2002 Aug; 26(3):255-60. PubMed ID: 12403490
[TBL] [Abstract][Full Text] [Related]
16. An alpha-thalassemic hemoglobinopathy: homozygosity for the HB Agrinio alpha 2-globin chain variant.
Traeger-Synodinos J; Metaxotou-Mavromati A; Kanavakis E; Vrettou C; Papassotiriou I; Michael T; Kattamis C
Hemoglobin; 1998 May; 22(3):209-15. PubMed ID: 9629496
[TBL] [Abstract][Full Text] [Related]
17. A Novel α2-Globin Gene Mutation: Hb Debao [α31(B12)Arg→Trp; HBA2: c.94A>T].
Lin L; Chen B; Yi S; Chen Q; Wei H; Li G; Zheng C; Qiu XX; He S
Hemoglobin; 2017 Jan; 41(1):65-67. PubMed ID: 28367658
[TBL] [Abstract][Full Text] [Related]
18. Hb Iberia [α104(G11)Cys → Arg,TGC>CGC (α2) (HBA2:c.313T>C)], a new α-thalassemic hemoglobin variant found in the Iberian Peninsula: report of six cases.
Bento C; Oliveira AC; Neves J; Gameiro M; Cunha E; Coucelo M; Costa RM; Barbot J; Costa E; Fernández-Lago C; Ribeiro ML
Hemoglobin; 2012; 36(6):517-25. PubMed ID: 23181747
[TBL] [Abstract][Full Text] [Related]
19. Hb Oegstgeest [alpha104(G11)Cys-->Ser (alpha1)]. A new hemoglobin variant associated with a mild alpha-thalassemia phenotype.
Harteveld CL; Rozendaal L; Blom NA; Lo-A-Njoe S; Akkerman N; Arkestijn S; Van Delft P; Giordano PC
Hemoglobin; 2005; 29(3):165-9. PubMed ID: 16114179
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2-globin gene mutation Hb G-Waimanalo: occurrence in combination with alpha-thalassemia-1.
Landin B; Berg P
Hemoglobin; 1994 Jan; 18(1):71-2. PubMed ID: 8195011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
